Can intravenous iron reduce transfusion rates in anaemic patients undergoing cardiac surgery?

Royal Wolverhampton Hospitals NHS Trust (UK)0 个研究点目标入组 50 人开始时间: 2013年1月30日最近更新: 2019年9月9日

试验速览

2017 results in British Society of Gastroenterology Annual General Meeting 2017 https://gut.bmj.com/content/66/Suppl_2/A113.2 2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/30107449 (added 14/08/2019)

•1. Aged 18 years or older
•2. Elective cardiac surgery
•3. Pre-operative haemoglobin (Hb) level >1g/dl below the normal range (i.e. women <11.5g/dl and men <12.5 g/dl)

•1. Pregnancy
•2. Patient participating in another trial
•3. Patients unable to give written consent
•4. Patients with a recognised allergy or other contraindication to intravenous iron or related products
•5. Low haemoglobin attributable to haemoglobinopathy
•6. Anaemia secondary to known co-existing and uncorrected B12 or folate deficiency
•7. Patients already receiving oral or intravenous iron treatment
•8. Patients with evidence of significant symptomatic anaemia which would normally require urgent transfusion at the time of assessment
•9. Patients with a Hb less than 9.0 g/dl

发起方

Royal Wolverhampton Hospitals NHS Trust (UK)